Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Mohamad Mohammadi"'
Autor:
Mohadeseh Arabsolghar, Mohamad Mohammadi, Amir Kaheh, Anahita Norouzifard, Sadegh Ahmadzadeh
Publikováno v:
Journal of Oral Health and Oral Epidemiology, Vol 4, Iss 1, Pp 24-29 (2015)
BACKGROUND AND AIM: Iran is located on the thalassemia belt and has the highest prevalence rate of patients compared to the general population in the world. This investigation was performed to determine the prevalence of gingivitis and periodontitis
Externí odkaz:
https://doaj.org/article/884e262abeeb45d8927f83dbe86f6c06
Autor:
Nassrin Mashaii, Farhad Rajabipour, Ahmad Bitaraf, Homayun Hosseinzadeh, Mostafa Sharif Rohani, Habib Sarsangi, Mohamad Mohammadi
Publikováno v:
International Journal of Food Science and Agriculture. 6:4-7
Autor:
Alireza Alinouri, Mohebi Siamak, Marzieh Shahsiah, Fatemeh Khansanami, Ali Mohamad Mohammadi Veldani, Shabanali Khansanami
Publikováno v:
Health, Spirituality and Medical Ethics, Vol 3, Iss 2, Pp 24-29 (2016)
Background and Objectives: Belief health and possession of proper religious beliefs are among hygienic priorities for effective and active strata of the society. False religious beliefs and adherence thereto lead human beings astray. The present stud
The frequencies and functions of discourse markers in the Iranian university EFL classroom discourse
Publikováno v:
International Journal of Research Studies in Language Learning. 4
Classroom discourse is the investigation of the models of classroom participation and is a comprehensive and multidimensional phenomenon. As semantically empty and functionally complicated linguistic devices, discourse markers assist the teachers and
Autor:
Mohamad Mohammadianpanah, Sasan Razmjoo Ghalaee, Bijan Khademi, Amin Shafizadeh, Shapour Omidvari, Ahmad Mosallaei, Niloufar Ahmadloo, Mansour Ansari
Publikováno v:
Iranian Journal of Otorhinolaryngology, Vol 21, Iss 56, Pp 55-62 (2009)
Introduction: Concurrent cisplatin-based chemoradiation is currently considered the treatment of choice for locoregional nasopharyngeal carcinoma. Celecoxib is a selective cyclooxygenase-2 (COX-2) inhibitor which can potentially enhance the effect of
Externí odkaz:
https://doaj.org/article/6dfae29490754fadb7baae0140692cdc